| Thromboembolism in heart transplantation: role of prothrombin G20210A and factor V Leiden. | |
| | |
MedLine Citation:
|
PMID: 16177630 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Thromboembolism has been reported as a frequent complication after cardiac transplantation. Many risk factors for thrombosis may explain this, such as metabolic alterations and the use of cyclosporine. In the general population, two single nucleotide polymorphisms (SNPs), factor V Leiden and prothrombin G20210A (PT G20210A), have been associated with a significant increase in the risk of thrombosis. However, these mutations have not been analyzed in cardiac transplant patients. We describe the protracted history of recurrent thromboembolism in a rare case of homozygosity for the PT G20210A variant. This prompted us to analyze the entire cardiac transplant cohort for the incidence of thromboembolic events and their association with these genetic polymorphisms. METHODS: We report the study of 84 cardiac transplant recipients. We retrospectively analyzed the frequency of thromboembolic episodes. The genotypes for FVL and PT G20210A were determined and correlated with those episodes. RESULTS: Our results confirm a very high incidence of thromboembolism in this population. We also found a significant increase in the likelihood of thromboembolism in subjects with the PTB G20210A variant (odds ratio 3.08; 95% confidence interval: 1.7-5.5). CONCLUSIONS: The incidence of thromboembolic complications after heart transplantation is increased and may be related in part to genetic predisposition. |
| | |
Authors:
|
Santiago G Miriuka; Loralie J Langman; Jovan Evrovski; Stephen E S Miner; Stella Kozuszko; Nisha D'Mello; Diego H Delgado; Betty Y L Wong; Heather J Ross; David E C Cole |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Transplantation Volume: 80 ISSN: 0041-1337 ISO Abbreviation: Transplantation Publication Date: 2005 Sep |
Date Detail:
|
Created Date: 2005-09-22 Completed Date: 2005-12-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0132144 Medline TA: Transplantation Country: United States |
Other Details:
|
Languages: eng Pagination: 590-4 Citation Subset: IM |
Affiliation:
|
Department of Medicine, Toronto General Hospital and University of Toronto, Ontario, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Factor V / genetics* Genotype Heart Transplantation / adverse effects, statistics & numerical data* Homozygote Humans Incidence Male Middle Aged Polymorphism, Single Nucleotide Postoperative Complications / mortality Prothrombin / genetics* Recurrence Retrospective Studies Risk Factors Survival Analysis Thromboembolism / epidemiology, genetics*, mortality |
| Chemical | |
Reg. No./Substance:
|
0/factor V Leiden; 9001-24-5/Factor V; 9001-26-7/Prothrombin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Long-term patient and graft survival in the eurotransplant senior program: a single-center experienc...
Next Document: HLA antigens and post renal transplant lymphoproliferative disease: HLA-B matching is critical.